Share
Save
Chemotherapy-induced Peripheral Neuropathy (CIPN) Clinical Trial
Join this clinical study and take a step toward finding a better solution for pain caused by chemotherapy.
Study details:
Suffering from pain? You may qualify to participate if you have been diagnosed with Chemotherapy-induced Peripheral Neuropathy (CIPN) following chemotherapy. This is a clinical research study to evaluate the benefits and safety of 10kHz Spinal Cord Stimulation for managing CIPN symptoms like nerve pain, numbness, and tingling after chemotherapy. Trial-related procedures and devices will be provided at no cost. Participants who qualify may be compensated for their time and travel.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Things to know
Study dates
Study start: 2024-12-12
Primary completion: 2024-11-15
Study completion finish: 2026-01-22
Study type
TREATMENT
Phase
PHASE1
Trial ID
SPMC-002
Intervention or treatment
DEVICE: Spinal Cord Stimulation
Conditions
- • Chemotherapy-induced Peripheral Neuropathy (CIPN)
Find a site
Closest Location:
Sydney Pain Management Centre
Research sites nearby
Select from list below to view details:
Sydney Pain Management Centre
Wahroonga, New South Wales, Australia
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!